Atlas Trials

A Study of JNJ-63733657 in Participants With Early Alzheimer's Disease

Clinical trial NCT04619420 · TERMINATED

Trial details

NCT number
NCT04619420
Sponsor
Janssen Research & Development, LLC
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Alzheimer DiseaseCognitive DysfunctionDementia
Start date
2021-01-06
Primary completion
2025-10-17
Enrollment
523

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.